...
首页> 外文期刊>Arthritis care & research >Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis
【24h】

Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis

机译:Certolizumab Pegol治疗后轴突性脊柱关节炎患者的葡萄膜炎发生率

获取原文
获取原文并翻译 | 示例
           

摘要

Objective. Axial spondyloarthritis (axial SpA) is characterized by inflammation of the spine and sacroiliac joints and can also affect extraarticular sites, with the most common manifestation being uveitis. Here we report the incidence of uveitis flares in axial SpA patients from the RAPID-axSpA trial, including ankylosing spondylitis (AS) and nonradiographic (nr) axial SpA.
机译:目的。轴突性脊柱关节炎(轴向SpA)的特征是脊柱和sa关节发炎,还可以影响关节外部位,最常见的表现是葡萄膜炎。在这里,我们从RAPID-axSpA试验报告了轴向SpA患者葡萄膜炎发作的发生率,包括强直性脊柱炎(AS)和非放射学(nr)轴向SpA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号